Evidence map›Paper›PMID 15124014›Full record

ArticleThe Journal of clinical investigation2004

Hold the antioxidants and improve plasma lipids?

Ronald M Krauss

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Ronald M KraussChildren's Hospital Oakland Research Institute, Oakland, California 94609, USA. rmkrauss@lbl.gov

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrahepatic proteolysis is a major determinant of secretion of ApoB-containing lipoproteins into plasma. Stimulation of post-ER presecretory proteolysis (PERPP) of ApoB by n-3 polyunsaturated fatty acids has been found to result in reduced secretion of VLDL particles by hepatocytes. A new study has shown that this stimulation is promoted by pro-oxidant conditions that result in increased hepatic lipid hydroperoxide content. Conversely, PERPP is suppressed by antioxidants and by saturated fatty acids, which are not susceptible to lipid peroxidation. Hence reduction of oxidative stress may have the unexpected side effect of increasing plasma lipid levels.

Indexed as

AntioxidantsApolipoproteins BEndoplasmic ReticulumFatty Acids, UnsaturatedHepatocytesHumansLipid PeroxidationLipidsLipoproteins, VLDLLiverModels, BiologicalOxidative StressProtein Processing, Post-TranslationalSignal TransductionAntioxidantsApolipoproteins BFatty Acids, UnsaturatedLipidsLipoproteins, VLDL

Identifiers

PMID15124014
PMCPMC398437
OpenAlexW2031962472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.